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Objective. To translate the EuropeanGeneral Practice ResearchNetworkmultimorbidity definition according to Portuguese cultural
and linguistic features. Methods. Similar to the process completed in several other European countries, a forward and backward
translation of the English multimorbidity definition using the Delphi technique was performed in Portugal. Results. Twenty-three
general practitioners (GPs)—14 males and 9 females—agreed to form the Portuguese expert panel for the Delphi process (59%
acceptance rate). The Portuguese definition of multimorbidity was achieved after two Delphi rounds with a mean (SD) consensus
score for final round of 8.43/9 (0.73). Conclusion. With this paper the definition of multimorbidity is now available in a new
language—Portuguese. Its availability in the local language will raise Portuguese GPs’ awareness about multimorbidity and allow
future national and international research. The operationalization of the definition will allow an easier identification of patients
with multimorbidity.
1. Introduction
Clinicians working in the primary health care context,
namely, family physicians and general practitioners (GPs),
deal with the broad spectrum of conditions affecting each
individual seeking a medical consultation. In this setting,
most of the time it is not possible to pinpoint an index disease,
nor is it useful for the patient’s care [1]. Therein lies the
main difference between comorbidity and multimorbidity;
the former always involves the presence of an index disease
[2]. Thus, the majority of GP visits comprise individuals
with multimorbidity [3]. The most frequent measure of
multimorbidity is the presence of 2 or more chronic diseases
in the same person [4]. Although this is a useful operational
definition, the construct of multimorbidity is still difficult
to define in clinical terms [5]. Recently, after a systematic
literature review, the European General Practice Research
Network published a comprehensive definition which states
that “multimorbidity is defined as any combination of chronic
disease with at least one other disease (acute or chronic)
or biopsychosocial factor (associated or not) or somatic
risk factor. Any biopsychosocial factor, any somatic risk
factor, the social network, the burden of diseases, the health
care consumption, and the patient’s coping strategies may
function as modifiers (of the effects of multimorbidity).
Multimorbidity may modify the health outcomes and lead to
an increased disability or a decreased quality of life or frailty”
[6]. This definition aims to be especially useful in long term
care and in family medicine settings [6] and at the same time
to be valid for future collaborative research [7]. For this last
purpose, it has been translated into ten European languages
[7]. The Portuguese language was not one of them.
In Portugal, the 40-year history of family medicine led
to the recognition of its importance in the country’s health
care delivery [8]. Multimorbidity is present in around 70%
of the adult patients attending primary care in Portugal [9],
and this high prevalence will produce significant difficulties
in the provision of medical care. Using a definition of multi-
morbidity in the country’s own language will standardize the
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Table 1: Characteristics of the expert panel.
Portuguese translation (𝑛 = 23) Global average of previoustranslations [7] (𝑛 = 229) 𝑃 value
Males, % 60.87 50.69 0.51∗
Mean (SD) age, years 45.78 (12.82) 48.26 0.36†
Mean (SD) years of practice 18.09 (13.28) 18.82 0.79†
Mean (SD) number of English publications 6.13 (7.12) 5.91 0.88†
Mean (SD) number of other publications 15.09 (15.24) 20.45 0.11†
∗Fisher’s exact test.
†Student’s 𝑡-test.
identification of multimorbid patients while simultaneously
enabling future collaborative projects as well as addressing
more effectively this overwhelming medical problem.
It is expected that this definition will have a broad suit-
ability to other Portuguese language settings and countries.
The British Council’s report “Languages for the Future” [10]
identifies Portuguese as one of the ten languages most vital to
UK over the next 20 years. With approximately 203 million
speakers, Portuguese is the sixthmost spoken language in the
world [10], the third most spoken language in the Western
Hemisphere, and the first most spoken language in the
Southern Hemisphere [11].
In this study, the authors aimed to translate the English
multimorbidity definition according to Portuguese cultural
and linguistic features using a forward-backward translation
by a Delphi technique.
2. Materials and Methods
Similar to the process completed in Bosnia, Bulgaria, Croatia,
France, Germany, Greece, Italy, Poland, and Spain [7], a
forward and backward translation of the English multi-
morbidity definition [6] using the Delphi technique was
performed in Portugal. This technique is easily adapted to
reach a consensus in a variety of issues [12], includingmedical
research [13].
The first phase involved translating the definition from
English to Portuguese (forward translation). This was done
by a team of one official translator and one physician; both
were native Portuguese speakers.
In the next phase the Delphi process was implemented.
Aiming at a sample size between 10 to 30 national expert GPs
as recommended by the European General Practice Research
Network [7], 39 possible participants were individually con-
tacted by email to receive the original Englishmultimorbidity
definition and its translation into Portuguese. GPs were
selected on the basis of having a Portuguese nationality,
being fluent in English (understanding/speaking/writing),
being involved in clinical practice, in research, and/or in
teaching activities, and having the willingness to dedicate
the time to this method of discussion. The expert panel was
requested to rate their level of agreement with the Portuguese
translation on a Likert-type scale ranging from 1 = “absolutely
no agreement” to 9 = “full agreement.” If a rating less than
7 was given it was mandatory to justify the reasons for that
evaluation. Consensus was defined as at least 70% of the GPs
rating 7 or above the Portuguese definition. If a consensuswas
not reached in the first round, the expert panel’s remarks were
compiled into a unified translation, and a subsequent round
of assessment was followed in the same way as for the first
one. This process was repeated until a consensual translation
was found. The participating GPs’ characteristics (gender,
age, years of practice, number of English publications, and
number of other publications) were collected by a self-
administered questionnaire conducted through email.
When a consensual Portuguese translation was reached it
was submitted to a Portuguese linguist from the University of
Coimbra (Portugal) for validation.
The final phase involved translating the consensual def-
inition in Portuguese to English (backward blind transla-
tion). This was done by a team of one official translator
(native English speaker) and one physician. They had no
previous knowledge of the original definition. Subsequently,
the authors of the study compared the back-translated version
with its original version for linguistic congruence and cultural
relevancy.
As no patient was involved in the study, no formal ethics
approval was necessary. Consent was inferred by participants’
completion of the survey.
A descriptive analysis was performed and both Fisher’s
exact test and Student’s 𝑡-test were used to compare the
current study’s expert panel with the panel of the previous
translations. 𝑃 values <0.05 were considered statistically
significant.
3. Results
Twenty-three GPs (14 males and 9 females) agreed to form
the Portuguese expert panel for the Delphi process (59%
acceptance rate). All members of the expert panel satisfied
the inclusion criteria. The profile of the Portuguese GPs did
not differ significantly from that of the previous translations
[7] (Table 1).
The Portuguese definition of multimorbidity was
achieved after two Delphi rounds with a mean (SD) con-
sensus score for final round of 8.43 (0.73). Only one expert
rated the forward translation below 7 (95.7% approval rate).
The expert panel produced 43 comments in total. The terms
which originated remarks were “burden of disease” and
“health outcomes.” Minor grammatical annotations were
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Table 2: Portuguese final translation and the backward translation.
Portuguese final version Portuguese final version translated into English
A multimorbilidade é definida como qualquer
combinação de uma doença crónica com pelo menos
uma outra doença (aguda ou crónica), ou com um fator
biopsicossocial (associado ou não), ou com um fator de
risco somático.
Multimorbidity is defined as any combination of
chronic disease with at least one other disease (acute or
chronic) or biopsychosocial factor (associated or not)
or somatic risk factor.
Qualquer fator biopsicossocial, qualquer fator de risco
somático, a rede social, a carga das doenças, o consumo
de cuidados de saúde e as estratégias de adaptação do
doente podem funcionar como modificadores (dos
efeitos da multimorbilidade).
Any biopsychosocial factor, any somatic risk factor, the
social network, the burden of diseases, the health care
consumption, and the patient’s coping strategies may
function as modifiers (of the effects of multimorbidity).
A multimorbilidade pode modificar os resultados em
saúde e levar a um aumento da incapacidade, à
diminuição da qualidade de vida ou à fragilidade.
Multimorbidity may modify the health outcomes and
lead to an increased disability or a decreased quality of
life or frailty.
frequently suggested, recorded, and incorporated into the
definition.
Table 2 shows the final consensual Portuguese definition
of multimorbidity and the backward translation as accepted
by the authors of this study. No changes were found in
comparison with the original English definition.
4. Discussion
With the current study the translation of the English multi-
morbidity definition into Portuguese was achieved.
No universal guidelines exist on how to apply the Delphi
technique [14]. Some authors have even stated that the
advantages and disadvantages of this method are equally
weighted [12]. Nonetheless, with methodological precision
and research rigour the Delphi technique can be properly
and efficiently used [14]. In the current study, the successful
methodology employed in previous translationswas adopted.
The Portuguese translation was the end result of the
reviews of an expert panel of practicing GPs that verified
that the terms expressed in the definition complied with the
ones in use in Portugal. The Portuguese panel had similar
characteristics to the average of the panels of the previous
translations [7]. This ratifies the thorough selection process
used to choose the GP experts in this study. The challenged
terms were the same as in the other countries’ translations;
this may be explained by the fact that those expressions are
less commonly used on a daily basis. In the second round
this was overcome and the backward translation did not
reveal any changes in comparison with the original English
definition.
5. Conclusion
With this paper the definition of multimorbidity is now
available in a new language—Portuguese. Its availability in
the local language will raise Portuguese GPs’ awareness about
multimorbidity and allow future national and international
research. The operationalization of the definition will allow
an easier identification of patients with multimorbidity.
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